Risk factors
Xeris Biopharma Holdings (XERS) risk factors
Item 1A of every Xeris Biopharma Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors74 risks4 new4 dropped16 reworded
Xeris added new disclosures addressing U.S. most-favored-nation drug pricing executive orders, CMS Medicaid payment initiatives, artificial intelligence risks, and social media compliance.
Filed Mar 02, 2026 - FY2024 10-K risk factors74 risks
Xeris Biopharma faces concentrated customer risk with four accounts generating over ninety percent of gross product revenue.
Filed Mar 06, 2025